Global X HealthTech ETF (NASDAQ:HEAL) Sees Significant Decline in Short Interest

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a significant decline in short interest in the month of February. As of February 13th, there was short interest totaling 1,547 shares, a decline of 74.3% from the January 29th total of 6,028 shares. Based on an average daily volume of 19,205 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the company’s shares are sold short. Approximately 0.1% of the company’s shares are sold short. Based on an average daily volume of 19,205 shares, the short-interest ratio is presently 0.1 days.

Global X HealthTech ETF Trading Down 0.9%

Shares of HEAL stock traded down $0.24 on Friday, hitting $26.61. 12,840 shares of the stock were exchanged, compared to its average volume of 15,437. Global X HealthTech ETF has a fifty-two week low of $24.48 and a fifty-two week high of $34.20. The business has a 50-day moving average of $28.63 and a 200 day moving average of $30.53. The firm has a market capitalization of $35.39 million, a P/E ratio of 42.80 and a beta of 1.13.

Global X HealthTech ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Wednesday, January 7th. Stockholders of record on Tuesday, December 30th were issued a dividend of $0.0718 per share. The ex-dividend date of this dividend was Tuesday, December 30th.

Hedge Funds Weigh In On Global X HealthTech ETF

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC raised its position in shares of Global X HealthTech ETF by 26,522.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock worth $70,000 after purchasing an additional 2,387 shares during the period. WT Wealth Management raised its holdings in Global X HealthTech ETF by 10.1% during the fourth quarter. WT Wealth Management now owns 88,171 shares of the company’s stock worth $2,576,000 after buying an additional 8,066 shares during the last quarter. Farther Finance Advisors LLC bought a new position in shares of Global X HealthTech ETF in the fourth quarter valued at $111,000. Flow Traders U.S. LLC acquired a new position in shares of Global X HealthTech ETF during the third quarter valued at about $368,000. Finally, Citadel Advisors LLC bought a new stake in shares of Global X HealthTech ETF during the third quarter worth about $216,000.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.